Trial on the Safety of a New Liposomal Adjuvant System, CAF01, When Given With the Tuberculosis Subunit Vaccine Ag85B-ESAT-6 as Two Injections With Two Months Interval to Healthy Adult Volunteers
Clinical trial NCT00922363 · COMPLETED
Trial details
- NCT number
- NCT00922363
- Sponsor
- Statens Serum Institut
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-01
- Primary completion
- 2011-10-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.